BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17155901)

  • 21. Targeting TGFbeta-mediated processes in cancer.
    Romano MF
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):253-63. PubMed ID: 19333871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells.
    Sokol JP; Schiemann WP
    Mol Cancer Res; 2004 Mar; 2(3):183-95. PubMed ID: 15037657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.
    Levy L; Hill CS
    Cytokine Growth Factor Rev; 2006; 17(1-2):41-58. PubMed ID: 16310402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of growth regulation by transforming growth factor-beta (TGF-beta) in human cancers: studies on endometrial carcinoma.
    Gold LI; Parekh TV
    Semin Reprod Endocrinol; 1999; 17(1):73-92. PubMed ID: 10406078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal carcinoma cell production of transforming growth factor beta decreases expression of endothelial cell vascular endothelial growth factor receptor 2.
    Kuczynski EA; Viloria-Petit AM; Coomber BL
    Cancer; 2011 Dec; 117(24):5601-11. PubMed ID: 21692070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-beta signaling in cancer treatment.
    Fabregat I; Fernando J; Mainez J; Sancho P
    Curr Pharm Des; 2014; 20(17):2934-47. PubMed ID: 23944366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage coculture enhanced invasion of gastric cancer cells via TGF-β and BMP pathways.
    Shen Z; Kauttu T; Cao J; Seppänen H; Vainionpää S; Ye Y; Wang S; Mustonen H; Puolakkainen P
    Scand J Gastroenterol; 2013 Apr; 48(4):466-72. PubMed ID: 23517295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer.
    Zhu H; Luo H; Shen Z; Hu X; Sun L; Zhu X
    Tumour Biol; 2016 Jun; 37(6):7075-83. PubMed ID: 27010470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.
    Nagineni CN; Samuel W; Nagineni S; Pardhasaradhi K; Wiggert B; Detrick B; Hooks JJ
    J Cell Physiol; 2003 Dec; 197(3):453-62. PubMed ID: 14566975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory machinery for the TGF-β family signaling pathway.
    Itoh S; Itoh F
    Growth Factors; 2011 Oct; 29(5):163-73. PubMed ID: 21913798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
    Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment.
    Huynh LK; Hipolito CJ; Ten Dijke P
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31744193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large- and small-molecule inhibitors of transforming growth factor-beta signaling.
    Akhurst RJ
    Curr Opin Investig Drugs; 2006 Jun; 7(6):513-21. PubMed ID: 16784021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
    Weeks BH; He W; Olson KL; Wang XJ
    Cancer Res; 2001 Oct; 61(20):7435-43. PubMed ID: 11606377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
    Bachman KE; Park BH
    Curr Opin Oncol; 2005 Jan; 17(1):49-54. PubMed ID: 15608513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta signaling in cancer--a double-edged sword.
    Akhurst RJ; Derynck R
    Trends Cell Biol; 2001 Nov; 11(11):S44-51. PubMed ID: 11684442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor β signaling pathway: A promising therapeutic target for cancer.
    Chen Y; Di C; Zhang X; Wang J; Wang F; Yan JF; Xu C; Zhang J; Zhang Q; Li H; Yang H; Zhang H
    J Cell Physiol; 2020 Mar; 235(3):1903-1914. PubMed ID: 31332789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression.
    Jones E; Pu H; Kyprianou N
    Expert Opin Ther Targets; 2009 Feb; 13(2):227-34. PubMed ID: 19236240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.